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Background: The increasing number of patients with chronic diseases represents a challenge for health care
systems. The Chronic Care Model suggests a multi-component remodelling of chronic disease services to improve
patient outcomes. To meet the complex and ongoing needs of patients, chronic disease prevention and
management (CDPM) has been advocated as a key feature of primary care producing better outcomes, greater
effectiveness and improved access to services compared to other sectors. The objective of this study is to evaluate
the adaptation and implementation of an intervention involving the integration of chronic disease prevention and
management (CDPM) services into primary health care.
Methods/Design: The implementation of the intervention will be evaluated using descriptive qualitative methods
to collect data from various stakeholders (decision-makers, primary care professionals, CDPM professionals and
patients) before, during and after the implementation. The evaluation of the effects will be based on a combination of
experimental designs: a randomized trial using a delayed intervention arm (n = 326), a before-and-after design with
repeated measures (n = 163), and a quasi-experimental design using a comparative cohort (n = 326). This evaluation
will utilize self-report questionnaires measuring self-efficacy, empowerment, comorbidity, health behaviour, functional
health status, quality of life, psychological well-being, patient characteristics and co-interventions. The study will take
place in eight primary care practices of the Saguenay region of Quebec (Canada). To be included, patients will have to
be referred by their primary care provider and present at least one of the following conditions (or their risk factors):
diabetes, cardiovascular diseases, chronic obstructive pulmonary disease, asthma. Patients presenting serious cognitive
problems will be excluded.
Discussion: In the short-term, improved patient self-efficacy and empowerment are expected. In the mid-term,
we expect to observe an improvement in health behaviour, functional health status, quality of life and psychological
well-being. At the organizational level, the project should lead to coordinated service delivery, improved patient
follow-up mechanisms and enhanced interprofessional collaboration. Integration of CDPM services at the point of
care in primary care practices is a promising innovation in care delivery that needs to be thoroughly evaluated.
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The last decades have seen dramatic shifts in the pattern
of diseases from infectious diseases to the current leading
causes of mortality dominated by chronic diseases (CD)
accounting for 59% of annual deaths and 46% of the global
burden of disease [1]. Research suggests that complex
chronic conditions such as diabetes, cardiovascular and
respiratory diseases will impose an even larger burden in
the future [1,2]. This represents a challenge for the health
care system. While traditional health care funding and
management are mainly designed to address acute health
conditions, the bulk of health funds are allocated to
patients with CD who are the heaviest users. In Canada, it
is estimated that 42% of total direct medical care expendi-
tures ($39 billion) are used each year to treat people with
CD [3]. Due to lack of coordination of care and difficulties
accessing services, patients with CD are disadvantaged in
the current health care system and are, together with physi-
cians, decision-makers and the general population, looking
for fundamental changes. Several solutions have been
proposed at the organizational and patient level.
From an organizational point of view, it has been demon-
strated that a strong primary health care system is associ-
ated with better health indicators and more sustainable
costs [4-9]. A recent report of the Canadian health care
authorities has put forward the added-value of a strong
primary health care system recognizing the role of primary
care as a pivotal organization ensuring proper use of profes-
sional skills in the management of chronic diseases [10].
However, patients with CD represent a greater challenge to
primary health care as they are associated with high health
care costs and poor compliance to treatment and recom-
mendations [11-13]. In the presence of CD, primary health
care providers face difficulties in applying guidelines [14,15]
and in maintaining care continuity [16]. To prevent poten-
tial health care system gaps in quality, efficiency, and effect-
iveness, the Chronic Care Model (CCM) has been
suggested as a promising solution. Hence, the integration
and application of the CCM into primary care organiza-
tions should be supported [17,18]. Although various stake-
holders do agree on the relevance of the CCM approach,
translating its conceptual clusters into operational strategies
is a complex undertaking. Consequently, decision-makers
and physicians have to consider reliable evidence-based
evaluations to improve quality of care and to manage
allocation of resources as efficiently as possible [19].
Lifestyle-related risk factors of CD, such as obesity, phys-
ical inactivity and diet-related behaviours, have been linked
to increased risks of morbidity and mortality [20]. This re-
flects the 40% of CD that can be prevented [21]. To meet
the complex needs of patients with chronic conditions seen
in primary care, these settings may benefit from being able
to offer a range of chronic disease prevention and manage-
ment (CDPM) services under one roof. Such integratedservices have been identified as a potential key to fulfilling
standards of care for patients with CD. To prevent primary
health care clinics from operating in isolation, CDPM
services have to be provided by an interdisciplinary team in
coordination with primary care. Interdisciplinary teamwork
has been associated with a higher use of preventive strat-
egies and a lower burden for caregivers [22]. Primary care
physicians are in the best position to coordinate these strat-
egies as they see patients more frequently and at earlier
stages of the disease than specialists. In the search for strat-
egies that might help reduce the burden of CD and related
high risk lifestyles, resource utilization and management
schemes deserve to be evaluated. This makes evaluation an
integral part of the implementation process.
In the Saguenay-Lac-Saint-Jean region of Québec
(Canada), health care professionals have been mobilized
to deal with the challenges of CD management through
the introduction of integrated CDPM services. Since
2001, a strong network of CDPM services has been
deployed in the six health care centers across the region.
The approach groups together various CD based on com-
mon CDPM services, with a range of standardized services
rooted in evidence-based medicine and integrated at the
local level into each of the six regional territories [23,24].
The program addresses a number of CD, including cardio-
vascular disease (CVD), heart failure, chronic obstructive
pulmonary disease (COPD), asthma and diabetes, and aims
to: (1) reduce and correct modifiable risk factors; (2)
strengthen individual self-efficacy; (3) optimize functional
autonomy, biopsychosocial balance and health; and (4)
support self-management [23]. The program offers a range
of activities (educational, counselling, follow-up) delivered
by various professionals on aspects such as compliance
with medication/vaccination, nutrition, physical activity,
smoking cessation, stress management and psychosocial
support [23]. The variety of services for a given patient are
scheduled over a six-month period and may include indi-
vidual or group meetings [25]. The program intervention
principles are based on complementary theoretical models:
McGill’s nursing conceptual model [26,27], the PRECEDE
model [28,29], and the Prochaska & DiClemente stages of
change model [30,31]. However, collaboration between this
network and the primary care providers has so far not been
optimal for several reasons and consequently the services
have not reached a large part of the population with CD.
Services were offered to people mainly after an acute
episode of care or hospitalization.
The Cochrane Collaboration published a review of the
effectiveness of care and services shared between primary
care services and specialized care for CD management;
however it was not possible to draw conclusions regarding
the effectiveness of integration interventions in this field
at the time [32]. Theoretically, this kind of shared care
model presents an opportunity to provide patients with
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continuity of care and management of comorbidity more
easily offered through primary care whose providers main-
tain responsibility for all aspects of patient health care be-
yond a single specific CD. In this regard, a recent Canadian
experience with interventions involving close collaboration
between primary care settings and CD management
services stressed the desirability of this integration [33,34].
The implementation in Alberta of an integrated services
network within primary care settings, based on close collab-
oration with specialized services, demonstrated a positive
impact on patients, professionals and the organization of
services. However, the total effects of this intervention are
still being investigated.
CDPM has been shown to be effective in the context
of CVD [35], COPD [36], asthma [37] and diabetes [38].
Usually offered in specialized settings, such interventions
have had different outcomes such as a decrease in the use
of health services, and improved functional status and
quality of life, most often in the short term. Overall, these
studies were conducted outside primary care practices and
were limited in time. Intervention models and theoretical
foundations underlying these programs are varied, but
most often were founded on a patient education interven-
tion conducted by different health professionals specialized
in CD and focused on supporting the modification of risk
factors and self-management.
To date, the appropriateness of using multidisciplinary
specialized professionals in the context of primary care
practices has been little studied. The few studies found
were conducted along the same lines as that of specialized
CD interventions, that is, in the context of a single disease,Figure 1 Intervention logic model.such as COPD and asthma [39], metabolic syndrome [40],
kidney failure [41], diabetes [42], or among people with
risk factors [43]. Again, interventions were based on
different approaches, mainly on self-management support
and patient education. The outcomes used vary greatly
from one study to another and include the use of services,
quality of life, various physiological indicators and risk
factor modification.
Among ongoing studies, Perula et al. published a study
protocol of an open, two-arm parallel, non-pharmacological
approach based on the promotion of a healthy diet and
physical activity to control cholesterol levels among
patients with hyperlipidemia in the context of primary
care [44]. The intervention is based either on motivational
interviewing or on the usual brief advice. The study
will assess the degree of dietary and physical activity
improvement, weight loss in overweight patients,
adherence to treatment guidelines as well as lipid
levels and cardiovascular risk.
This study aims to introduce a pragmatic innovation
by adapting and integrating CDPM services into primary
care settings and to propose an innovative combination
of strategies to evaluate the effects and implementation
of this intervention in eight primary care practices in the
Saguenay region. The main components of this interven-
tion are illustrated in the intervention logic model
presented in Figure 1. The evaluation-specific objectives are
to: (1) assess the implementation of a clinical intervention
of CDPM services integrated into the existing structure of
the primary care network in order to describe the imple-
mentation context, the implementation process and the
satisfaction of those involved, including the perspective of
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terventions among primary care patients. We hypothesize
that patients receiving the intervention will report better
empowerment and self-efficacy and will demonstrate
reduced health risk behaviours.
Methods/Design
Settings
The intervention will be implemented in the Saguenay
region of Quebec (Canada) where primary care physicians
work in two types of organizations principally: Group prac-
tices, involving a group of primary care physicians working
in a team with no access to professionals from other disci-
plines; Family Medicine Groups, new organizations in
which primary care physicians work with nurses at various
degrees of collaboration and share the same patients
and medical files. No other disciplines are involved in
the practice. Both organizations provide care for a
population including a majority of patients with chronic
diseases and risk factors.
Intervention
The clinical components of the intervention consist of
many steps described in the logic model developed for
this project (Figure 1). According to the needs expressed
by primary care professionals, a number of patient-
centered activities were developed. CDPM services were
adapted to services and resources already in place with a
focus on self-management support, patient-centered care,
motivational interviewing, interprofessional collaboration
and integration of services. Such a multi-dimensional
learning package is designed to improve both process and
outcome measures and increase intervention impact. This
model has proven to be effective in the development of
behavioural interventions in patients with CD [45].
Further detail on the intervention is provided in Table 1.
The intervention will be implemented using support
mechanisms and ongoing evaluation within the par-
ticipating clinics to ensure a harmonious integration.
Interventions at the patient level will: (a) be patient-
centered and educational in nature; (b) last less than
three months and involve at least three encounters
with CDPM practitioners; (c) include individual inter-
views or patient focus groups involving close rela-
tives. The intervention will consolidate the central
role of primary health care professionals and their
organizations, while maintaining the natural proxim-
ity between the patient and his or her family phys-
ician. In this regard, interventions will: (a) be carried
out upon referral from the primary care team; (b)
allow an exchange with the primary care team and
will be recorded in primary care medical records; (c)
return the responsibility of long-term follow-up to
the primary care team.Evaluation
Consistent with the logic model (Figure 1), the evaluative
approach will focus both on the implementation of the
intervention and the measurement of its effects by using a
mixed methods design [46] to evaluate health interventions
[47]. The implementation evaluation will involve descriptive
qualitative methods, while the evaluation of the effects will
be based on quantitative methodology. This combination of
approaches used concomitantly aims to deepen our under-
standing and to corroborate the evaluation results.
Implementation evaluation (objective 1)
Implementation evaluation consists in investigating the re-
lationship between an intervention and its context during
implementation [48]. It will be based on two approaches: a
realistic evaluation, aiming to explain how various contexts
influence observed effects [49], and a participatory evalu-
ation aiming to determine the elements that could poten-
tially inform and help improve future interventions and
decision-making [50]. A realistic evaluation recognizes that
any effect (E) of an intervention arises from the interaction
between the intervention (I) and the context of its deploy-
ment (C). It aims to highlight the underlying mechanisms
as well as the way they operate under certain conditions.
Information about these three elements (E, I and C) will be
collected during all three stages of the implementation.
Moreover, realistic evaluation recognizes that results can
be apparent not only at patient-level but also at the level of
the professionals and organizations involved [51].
The participatory evaluation approach will help to
adapt both the data collection tools and the data analysis
strategy in order to bring to light elements that can
guide future intervention implementations.
Table 2 describes the implementation evaluation focus
(context, intervention or effects) that consists of three
phases (pre-, per- and post-intervention) and will be
conducted among the five categories of partners involved
in the project (decision-makers, n = 15; primary care phy-
sicians, n = 63; clinics, n = 8; specialists, n = 12; CDPM
professionals, n = 20; patients and their families, n = 326).
Patients (5 per clinic, total = 40) and their families (spouse
or main family caregiver) will be invited to take part in
focus groups.
To ensure fidelity of the intervention and to prevent
clustering, the intervention was designed by the research
team. Nevertheless, in this regard the research team
consulted with primary health care providers in each prac-
tice, specialists, and decision-makers to ensure that the
intervention is adapted to the needs expressed. Moreover,
interventions will be done by CDPM professionals,
recruited and trained by the research team about the gen-
eral principles of self-management support, patient-
centered care, motivational interviewing, interprofessional
collaboration and integration of services. The rationale of
Table 1 Characteristics of the interventions
CDPM practitioner
training
Theoretical training on:
− Motivational interviewing
− Function of the respiratory system
− Function of the cardiovascular system
− Diabetes
− Risk factors
− Existing CDPM services
Practical training:
− Three-week mentoring in specialized CDPM
services facilities.
Preliminary clinical
evaluation
The clinical evaluation of participants includes:
− Anthropometric characteristics
− Medical history
− Medication
− Functions (respiratory, cardiovascular,
endocrine, gastro-intestinal)
− Lifestyle habits and risk factors
− Patient preoccupations and objectives
− Previous interventions (nutrition, physical
activity, respiratory, smoking cessation)
− Recent changes (weight, alcohol
consumption)
Disciplines involved in
the intervention
The interventions, based on a referral from a
family physician or nurse, are provided by
professionals in the following disciplines:
− Clinical coordination
− Nursing
− Physical activity therapy
− Nutrition
− Respiratory therapy
− Smoking cessation therapy
Implemented
interventions
The interventions implemented are:
− Self-management support
− Education on diseases (diabetes, COPD,
asthma, cardiovascular)
− Education on risk factors (pre-diabetes, high
blood pressure, dyslipidemias, obesity,
physical inactivity, smoking)
− Counseling on medication
− Motivational interviewing
− Education about nutrition
− Education about physical activity
− Counseling on smoking cessation
Tools and support
material
Each intervention is supported by print and
other material to ensure that patient
engagement is maintained even between the
interventions. These include documents on:
− Chronic disease management
− Asthma, COPD
Table 1 Characteristics of the interventions (Continued)
− Diabetes
− Cardiovascular
− Metabolic syndrome
− Hypo/hypertension
− Tools for smoking cessation
− Stress management
− Blood pressure monitoring journal
− Personal objectives journal
− Physical activity journal
Communication &
coordination
The CDPM practitioners in our study work
within primary care settings which enhances
communication with primary care physicians,
nurses and staff. The clinical coordinator ensures
optimal communication and transition of care
between the project team, the primary care
professionals and specialized services. Special
attention is given to the distinction of tasks
fulfilled by project CDPM practitioners and
tasks fulfilled by primary care nurses.
Integration Prior to the implementation of interventions,
a pre-implementation evaluation is conducted
to identify the needs for CDPM services and
the contextual factors of the participating PC
clinics in the follow-up of CD patients. The
pre-implementation evaluation of the project
promotes the sharing of a common positive
vision of an intervention that focuses on
prevention, earlier support for patients in the
course of their disease, interprofessional
collaboration, services integration, motivational
interviewing and self-management support.
Participating primary
care professionals
Participating primary care professional include:
− Family physicians (63)
− Nurses (5)
Participating primary care settings:
− Four (4) clinics
− Four (4) family medicine groups
Participating
specialists
Participating specialists include:
− Cardiologists
− Internal medicine specialists
− Endocrinologists
− Pneumologists
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within and across the eight clinics in order to prevent study
interventions from evolving differently, as results will be
unusable if participants experience different interventions.
However, despite the use of such patterns, heterogeneity
that may be observed and documented between clinics in
terms of outcomes produced, termed “center effects” is part
of the pragmatic design and will reflect the clinical reality
of primary health care. It has been suggested that interven-
tions may be affected by center-specific issues and charac-
teristics such as degree of sub-specialization within
Table 2 Implementation evaluation
Evaluated dimensions Decision-makers Primary
care prof.
Specia-
lists
CDPM
prof.
Patients/family Patient
records
Project
documentation
Pre-intervention stage
Description of settings
(contextual factors) (C)
FG FG II FG
Needs analysis (C) FG FG II FG
Intervention stage
Identification of problems and difficulties (C) Document analysis
Care and services for patients (I)
(Intervention fidelity)
Checklist entry
Post-intervention stage
Extent of implementation/Services
offered (I)
II Data entry
Opinion on the implementation process (C) FG FG FG
Description of effects on
professionals/organizations (E)
FG FG FG
Care and services for patients (I) FG FG
Identification of barriers and
facilitating factors (C)
FG FG II
Satisfaction with intervention (E) FG FG II FG
FG: Focus group; II: Individual interview; C: Context; I: Intervention and action mechanisms; E: Effects of the intervention at the patient, practitioner and
organizational levels.
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however, we believe that delivering interventions by practi-
tioners who evolve through the same training process will
reduce clustering effects so that the experiment can be rep-
licated across centers and over time [53]. This desired ob-
jectivity is based on the involvement of systematic recourse
to the collective production of evidence and requires
standardization of practices within settings in order to pro-
duce replicable findings which can then be used to
standardize practice within, and across, clinical care settings
[54]. Moreover, efforts will be made to increase the number
of participants in each setting in order to reach a certain
degree of comparable statistical weight for every practice.
Throughout the implementation phase, information about
interventions offered to each patient will be collected with
a standardized checklist filled out by the CDPM profes-
sionals after each appointment to ensure the fidelity of the
intervention [55].
This study includes an evaluation process that mea-
sures the integrity and feasibility of the implementation
interventions and clinical interventions that will be used.
Furthermore, the study will assess how the interventions
are executed, will distinguish between components of
the interventions, and will identify contextual factors
that may influence the content and effectiveness of the
implementation intervention. The process evaluation
will also examine how well the interventions were
adapted to local barriers and facilitators.Data collection
Based on the categories of participants (patients/families,
primary care professionals, specialists, decision-makers),
four data collection strategies will be used within in-
depth multiple case studies with embedded levels of ana-
lysis [56]. The proposed strategies are as shown in
Table 2:
a. Focus groups (FG) to examine opinions and
reactions and to establish a collective understanding
of the evaluation aspects proposed [57]. These FG
will be conducted by an experienced interviewer
using interview guides with open-ended questions
developed for each level of analysis, in order to
obtain information on the identified dimensions;
b. Semi-directed individual interviews (II) conducted
with specialist physicians and CDPM professionals;
c. Patient files (5 per clinic) will be reviewed, using an
extraction grid. This review will serve both to clarify
how the range of services at the level of patients has
been operationalized, and to highlight elements of
services integration;
d. Analysis of documentation: Several documents
produced during the intervention implementation
(checklist for the intervention fidelity report,
summaries of team meetings, etc.) will be analyzed
to provide an in-depth understanding of the various
contexts in which the intervention was deployed, in
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that were encountered: committee meeting reports,
the clinical project coordinator’s notes, internal and
external announcements to various professional and
non professional communities, etc.Data analysis The data collected from all participants
(patients/families, primary care professionals, specialists,
decision-makers) during individual interviews and focus
groups (transcription of audio recordings and observer
notes) will be analyzed using content analysis. Following
an inductive approach combined with thematic analysis,
these analyses will be done in three steps to identify
emerging themes and trends. The first step is the “cod-
ing” which consists of reading and analyzing the corpus.
Data management software (NVivo 9.0, QSR Int. USA)
will be used to identify units of meaning that will be
grouped into nodes that will help extract information re-
lated to the same subject. The second step is “sorting”
the information into codes or code combinations that
will be reviewed and sorted according to different con-
texts. This information can then be broken and grouped
differently from the original version. The last step is
“analysis” that will be done throughout and after the
coding process. This phase will allow us to analyze all
the coded extracts from various documents. In addition
to revealing the specific elements of each of the imple-
mentation assessment dimensions that were chosen, ana-
lysis at this stage will specifically seek to deepen our
understanding of the interaction between the intervention,
its context and its effects. Contextual determinants of the
changes will be investigated using various explanatory
models, including political, structural and psychological
ones [48,58].Evaluation of effects (objective 2)
Effects will be assessed using three different strategies.
To measure short-term effects, a pragmatic randomized
experimental design with delayed intervention in the
control group will be used [59]. The first step of
randomization is the sequence generation using a simple
random allocation sequence. The second step is alloca-
tion concealment by development and allocating con-
cealment mechanism (sequentially numbered, sealed,
opaque envelopes) followed by preparation of the alloca-
tion concealment mechanism using the sequence from
step one. Research team members involved in generation
and allocation concealment will be different from the
team members involved in the implementation of assign-
ments. Thus, the intervention group allocation system is
set up so that the team member enrolling participants
does not know in advance in which group the next person
will be allocated.Patients will be referred by primary care providers
(family physician or nurse) to the research team who will
be responsible for assessing eligibility and obtaining
informed consent, as well as baseline measures (T1). For
each study participant, a research assistant at the central
office will open a numbered and sealed envelope. The
card inside will tell if the patient will be in group A or in
group B. This information will immediately be provided
to the patient and subsequently to the clinical team in
order to schedule the clinical interventions.
Because participants will be invited to receive the
interventions in their usual clinics, blind randomization
is not possible. Both patients and health care providers
will know who is involved in each group, therefore we
used independent (unmatched) random samples of
patients to receive the intervention immediately after
baseline assessments (Group A: immediate intervention
group) or at the end of a three-month waiting period
(Group B: delayed intervention group). We chose this
randomization process because of the potential proxim-
ity of patients in and between clinics. In practice, how-
ever, we think that communication between patients of
the same clinic or between clinics is scarce and will not
pose a substantial threat for contamination.
Since it is possible that participants in different groups
and phases might come in contact with each other as
many will be recruited in the same practice, some pre-
cautions will be taken in order to minimize the before
and after evaluation biases. To prevent selection bias,
the rigorous randomization methodology and allocation
concealment process described previously will be
respected throughout the project. The methods were
reviewed and approved by the Research Ethics Board of
the CSSSC and the measurement tools were validated.
We expect a response rate greater than 80% and baseline
measurements will be comparable in the sense that no
significant differences will exist between the groups with
respect to age, gender and pre-test measurements. If
necessary, the statistical models will be adjusted to
ensure comparability of the groups. Each subject inter-
vention will last less than three months and the clinical
intervention period is limited to 12 months in order to
ensure a contemporaneous data collection.
As stated in the logic model, with the three-month
delay design we seek to examine: (1) whether the imme-
diate intervention group (Group A) will have changes at
3 months that are sustained; (2) whether there will be
changes in the first 3 months before the intervention
with Group B; (3) whether the short-term results of
Group A will be different from those of Group B; and
(4) whether the outcomes of Group A can be sustained
one year later. Theoretically, it is anticipated that these
short-term results in attitudes and behaviors of patients
will be the precursors of the mid-term changes expected
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and psychological well-being.
In each clinic where the intervention will be deployed,
patients eligible to receive the intervention must be be-
tween 18 and 75 years of age and present at least one of
the following conditions: diabetes, cardiovascular dis-
ease, chronic obstructive pulmonary disease (COPD),
asthma or risk factors (smoking, obesity, dyslipidemia,
glucose intolerance, and metabolic syndrome). Patients
with serious cognitive problems will be excluded.
The decision to explore all these chronic conditions
together was preferred to the single disease design for
many reasons. The first reason is that this project is an
adaptation of CD specialized services already deployed in
the region for these chronic conditions into an integrated
network. Although these services have often been cited as
an example of the successful integration of CDPM ser-
vices, this approach still faces several challenges requiring
a review of its operations and organization to better reflect
the reality of patient follow-up and needs. To ensure
greater accessibility and better post-intervention continu-
ity, it has been noted that closer collaboration with pri-
mary care professionals such as family physicians and
nurses from various primary care settings will be neces-
sary in the next few years. Thus, all services for patients
with a CD could be provided in an integrated and ongoing
fashion. The second reason is that multifaceted interven-
tions are more effective than single ones [60], and sustain-
able change requires a multi-level approach especially
when multiple interventions at varying levels are
interlinked and mutually reinforced to maximize the im-
pact on patient behaviour, life-style and self-management.
This approach involves action at the patient, practitioner,
health care provider and service organization levels in
delivery and support. This study aims to provide guidance
to patients through trained practitioners working within aTable 3 Variables and outcome measures
Short-term: Key measurements of effect (measured at T1 and T2 in Groups
Self efficacy The Self-Efficacy for Ma
Stanford Patient Educa
Empowerment Proxy of “The Health Ed
Comorbidity The Disease Burden Mo
Mid-term: Key measurements of effect (measured at T1 and T3 in Groups A
Health behaviour Behaviour Risk Factor S
alcohol consumption)
Functional health status/quality of life SF -12 [63,78]
Psychological well-being K-6 [62]
Comorbidity The Disease Burden Mo
Other variables
Participant characteristics Sex, age, socioeconom
Co-intervention Questionnaire on co-inhealth care system that must be responsive to long-term
patient needs through its services and patient-centered
approach. Accordingly, we have adapted the CDPM
professional training so the interventions can be delivered
in primary care settings. The selection of these targeted
CD (diabetes, cardiovascular disease, asthma, COPD and
risk factors for these diseases) is based on a pragmatic
approach that aims to enrol patients whose characteristics
are similar to those most frequently seen in primary health
care settings.
To comply with the pragmatic nature of the intervention,
it is up to the referring professional (primary care physician
or nurse) to determine eligibility. For each patient, the re-
ferring professional will request the patient’s authorization
to disclose his or her contact information to the research
team and then complete a referral form. Patients refusing
to take part in the study will still be eligible to receive the
intervention without being involved in the evaluation
process. Two patients from the same family can receive the
intervention, but only one (randomly selected) will be
asked to participate in the research project.
Patients agreeing to participate will complete an initial
set of questionnaires at baseline (T1) collecting the main
variables and sociodemographic data. Patients will be
randomized to receive either the intervention within a
short period of time (Group A) or later (three months
later for Group B). At time 2 (T2), which will occur
three months after the intervention for Group A or im-
mediately before the intervention for Group B, patients
will complete the second evaluation questionnaire. Base-
line measures will be used to document equivalence be-
tween groups while T2 measures will enable the
assessment of the effect after three months. A short
questionnaire documenting co-interventions will also be
administered at T2 (Table 3). Co-interventions represent
any additional health care or CDPM services and/orA and B)
naging Chronic Disease (SEM-CD) scale (6 items) developed by the
tion Research Center [67].
ucation Impact questionnaire (heiQ)” [77]
rbidity assessment (DBMA) [64]
and C)
urvey System Questionnaire (eating habits, physical activity, smoking and
[65]
rbidity Assessment (DBMA) [64]
ic status, education, referral diagnosis
terventions
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http://www.biomedcentral.com/1472-6963/13/132therapeutic procedures other than those that are formally
included in the study and may introduce confounding
variables that could potentially affect the validity of the
results of this study.
To document the effect over a year (mid-term), a
repeated measures design is proposed. Thus, all patients
in Group A will be reassessed a third time (T3), one year
after T1. The T3 questionnaire will be identical to the
one used at T1 and T2 (Figure 2).
Finally, a quasi-experimental design with a non-
equivalent group will be used to evaluate mid-term effects.
The control group (Group C) will come from the PRECISE
research program platform (main investigators: Jeannie
Haggerty and Martin Fortin, www.programmeprecise.ca)
[61]. The PRECISE study is a cohort of 2197 adults aged
25-to-75 years followed for 4 years. The target population
is community-dwelling adults undifferentiated by disease,
who sought primary health care locally, did not suffer from
major cognitive impairment, and were able to respond to
written and oral questions in English or French. Partici-
pants were randomly selected within the geographicRefusal
Group A (163
Intervention
Evaluation 
Patient-MD shared selection of nee
interventions – Patient Referred to PR
Contact with patient - Assessmen
eligibility - Discussion about the st
informed consent
Intervention Intervention
Medical consultation 
(Family MD)
Evaluation 
month 0
month 3
month 6
month 12
Figure 2 Study timeline.boundaries of four local health care networks in Québec
(Canada). At recruitment (T0), cohort participants re-
ported on sociodemographic information, functional health
and health care use. Two weeks (T1), 3 months (T2) and
12 months (T3) after recruitment, they completed a self-
report questionnaire on their current health, health behav-
iours and primary health care experience in the previous
year. Use of medical services is confirmed through the
review of administrative databases. As in the present study,
the PRECISE cohort’s main dependent variable is func-
tional health status and quality of life which are measured
with the second version of the Short-Form-12 survey
(SF-12v2) [62,63]. Comorbidity is measured using the
validated Disease Burden Morbidity Assessment [64].
Lifestyle and health behaviour (eating habits, physical activ-
ity, smoking and alcohol consumption) are measured using
the Behavioral Risk Factor Survey System Questionnaire
[65]. This unique longitudinal cohort in Canada that is pro-
viding valuable information on the effectiveness of care in
the general population rather than in clients of selected
care models will offer us the opportunity to measure healthPRECISE cohort 
Acceptance
) Group B (163)
Delayed Intervention
T2
Randomisation
ded 
1MaC 
t of  
udy - 
Evaluation T2
Evaluation T1
Intervention
T3 Evaluation T3
Group C (163)
Control Cohort
Evaluation T1
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different models of CDPM services.
Patients from this cohort will be matched with patients
from Group A by age, gender, diagnosis and family income.
Groups will be compared on the basis of changes
over a year.
Variables and outcome measures The variables
presented in this section were selected to estimate
the effects based on the study objectives and the logic
model of the intervention. The variables that will be
collected according to the measurement schedule are
enumerated in Table 3.
Sociodemographic characteristics include gender, age,
education, revenue, marital status, and occupation. Health
status includes physical functioning, role limitations
because of physical health problems, bodily pain, general
health perceptions, vitality (energy/fatigue), social func-
tioning, role limitations because of emotional problems,
and general mental health (psychological distress and
psychological well-being). These dimensions will be inves-
tigated using the SF-12 that is a multipurpose short-form
(SF) generic measure of health status. The SF-12 Health
Survey includes 12 questions from the SF-36 [66].
Level of perceived disease-management self-efficacy
will be evaluated using the 6-item Self-Efficacy for Man-
aging Chronic Disease (SEM-CD) (Stanford Patient Edu-
cation Research Centre 2007) [67]. Each item consists of
a question asking how confident the subject feels in dif-
ferent aspects of disease self-management. The observed
range is from 1 to 10, with a higher number indicating a
greater level of perceived disease-management self-
efficacy. The score for each item is summed and then
averaged to yield the mean self-efficacy score. This self-
efficacy score has been shown to be responsive to
change following intervention in chronic disease self-
management [68].
The Health Education Impact Questionnaire (HeiQ)
provides a broad profile of the potential impacts of patient
education interventions [69]. HeiQ evaluates health educa-
tion (imparting skills) impact as well as larger psychosocial
(empowerment) impact.
The Kessler psychological distress scale K-6 is a measure
of nonspecific psychological distress that is sensitive to
discriminating community DSM-IV cases from non-cases
in the general population [70,71]. K-6 is a score derived
from the sum of the scores of the responses to each of the
six questions on mental illness.
The Disease Burden Morbidity Assessment (DBMA)
and a questionnaire on health behaviours (eating habits,
physical activity, smoking and alcohol consumption) will
be used to characterize patients in different groups.
Moreover, referral diagnoses, comorbidities and selected
interventions will be evaluated in each group.Data analysis We will first describe participants’ character-
istics in each group, using means and standard deviations
for continuous variables, and percentages for categorical
variables. The t-test (for continuous variables) and the chi-
square test (for categorical variables) will be used to
compare baseline characteristics across study groups.
To evaluate short-term effects, Groups A and B will
be compared on T2 scores (continuous variables such as
self-efficacy, health education impact) with an analysis of
covariance (ANCOVA) adjusted for T1 scores [72]. If
the groups differ at baseline despite randomization, the
ANCOVA will also be adjusted for the relevant variables
[73]. The independent variable “Group” will be tested
for significance at the 5% level.
To document effects over a year, a repeated measures
analysis of variance will be used to study the evolution
of continuous variables collected three times in Group A
[74]. Mid-term effects will be evaluated by comparing
T3 measurements in Group A (modifiable risk factors,
functional health status and psychological well-being)
with the same variables measured in Group C (from the
PRECISE cohort) using an ANCOVA adjusted for T1
scores and non-equivalent baseline characteristics (variables
not used for matching) [73]. Since groups A and C will be
matched on four variables only, they will be considered
independently in the analysis. Again, the variable “Group”
will be tested for significance at the 5% level.
Sample size and statistical power The required sample
size for the randomized clinical trial was calculated for the
two main variables (measured with the SEM-CD and the
heiQ) with a two-sided α = 0.05 and 80% power. First, for
continuous scores, 64 participants in each group will allow
to detect a medium effect size (ES=0.5) [75]. In addition,
for the heiQ, results are also expressed as the percentage
of patients improving at least half a standard deviation. In
a before–after study, 35% of patients receiving the inter-
vention presented an improvement of this magnitude [69].
Using these data in a conservative scenario providing for
improvement in 20% of control participants, 138 patients
are required in each group to detect a 15% difference.
Accounting for an anticipated drop-out rate of 15%, 326
patients will be randomized, 163 in each group. A smaller
ES of 0.34 will thus be detectable for continuous scores.
Comparison of the 138 subjects in Group A, re-
measured at T3 to the same number of subjects selected
in the PRECISE cohort, will also allow detection of an
ES of 0.34 when measuring mid-term effects (α = 0.05,
power = 80%). An additional 15% will also be enrolled in
anticipation of withdrawals.
Limitations and biases
Although conducting a randomized clinical trial may
present a challenge in clinical settings where some
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are waiting for the intervention (Group B), the short
period of time between randomization and the second
measurement will limit the possibility of co-interventions
and maturation biases. Nonetheless, given the pragmatic
nature of the trial, patients will be free to seek information
beyond the proposed intervention. This may contribute to
improve the observed effect. Co-interventions will be
evaluated by questionnaire and will be taken into account
in the analysis. In addition, analysis of the implementation
will bring qualitative insight to this phenomenon. The
repetition of the questionnaires may induce a learning
effect; however, the time between each execution is long
enough to reduce it.
The study design and its short term outcomes measure
have been developed specifically to address the problem
of the short period between T1 and T2. The project’s
proposed two-year timeframe does not allow any explor-
ation of the long-term efficacy of interventions on the
use of the health care system.
The intervention may differ from one setting to another,
but action will be taken to minimize this risk. We will out-
line the major considerations that may contribute to a
variation in intervention or its fidelity at each stage.
The decision to measure psychosocial outcomes only is
based on theoretical reasons that such outcomes are
particularly pertinent to examine the adoption and main-
tenance of a healthy lifestyle and a better quality of life.
One potential bias is the recruitment bias, where
health care providers recruit differently depending on
their practice, which leads to selection bias and lack of
comparability [76]. Recruitment for the present study is
prior to allocation which will be provided by the research
team. We will pay particular attention to find out whether
patients are comparable from one participating setting to
another as each primary health care professional will
select and refer his or her patients and each participating
setting has its own distinct contextual variables.
Feasibility
After a six-month implementation phase, the study
will take place over 18 months and will involve eight
medical clinics. To recruit 326 patients for the study
and meet the minimal time between intervention and
effects in one year, patient selection will need to be
done within six months. At the very conservative
mean rate of two patients per week per clinic, this
objective should be easily achieved. Pairing 138
patients with the PRECISE cohort with a potential
pool of 2197 patients from the waiting rooms of medical
practices is feasible. With regard to health care pro-
viders in clinical settings, a survey was conducted in
September 2010 that showed their willingness to
participate.Ethical considerations
The project received approval by the research ethics
committee of the Centre de santé et de services sociaux
de Chicoutimi. Informed consent will be obtained from
all participants. For ethical reasons, patients who decline
to participate will still be offered the intervention in
their clinic. For patients willing to participate, the three-
month waiting period for the delayed intervention group
(group B) will have a negligible effect, given the chronic
nature of their conditions. Informed consent will be
sought from each participant for the use of administrative
data. Confidentiality will be ensured and the data will be
stored according to the rules and recommendations of the
research ethics committee.
Discussion
In the short-term, we are expecting improved patient
self-efficacy, empowerment and self-management. In the
long-term, this should result in a reduction of their risk
factors, with an improvement in quality of life and psycho-
logical distress. At the organization level, the project should
lead to coordinated service delivery, improved patient
follow-up mechanisms and enhanced interprofessional
collaboration.
Health care program evaluation represents an im-
portant step in the adaptation of evidence-based
medicine to primary health care reality. Evaluations
should be planned, conducted, and reported in ways
that facilitate follow-through by stakeholders and
decision-makers. Reports should clearly describe the
health care program being evaluated, including its
context, purposes, procedures, findings and recom-
mendations, so that essential information is provided
and easily understood. Patients with CD are among
the highest users of health care services. It is import-
ant to increase our understanding of primary health
care needs for CDPM services and the characteristics
of conceptual models of interventional approaches
designed for patients with CD who are followed by
family physicians.
The study protocol aims to adapt and integrate CDPM
services into primary health care settings and to use
innovative strategies to evaluate the processes and effects
of such interventions.
In conclusion, the integration of CDPM services in
primary health care practices is a promising care delivery
innovation that needs to be thoroughly evaluated. Suc-
cessful implementation of health care reform requires
new concepts and directions that are strongly supported
by objective outcome measures. Continuous program
evaluations will facilitate the achievement of the primary
goal of the health care improvement debate: high-quality
care for every patient notwithstanding the nature or
number of his or her diseases.
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